Overview

Remdesivir Efficacy in Coronavirus Disease

Status:
Completed
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
COVID 19 treatment using Remedesvir.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Tanta University
Treatments:
Chloroquine
Chloroquine diphosphate
Ivermectin
Niclosamide
Nitazoxanide
Remdesivir